BioSpace News Archive

Ascension Healthcare plc announces positive findings from its Flexiseq User Experience Study.

CENTOGENE revealed the growth in its knowledge-base of rare hereditary diseases.

Bittium Wearable Platform with Philips EmoGraphy & CardioSense Solution Was Awarded in the GSK’s “Transform the Future of Self-Care” Innovation Contest

Abveris, Inc., a global leader in contract research antibody discovery, and Harbour Antibodies H2L2 BV, a wholly-owned subsidiary of Harbour BioMed, today announced a partnership to offer fully-human antibody discovery service that combines Abveris’ antibody discovery services with the Harbour H2L2 human transgenic mouse platform.

The emergence of targeted therapies for the treatment of bone cancer is expected to drive market growth.

Lark DMP users decreased A1c by 1.1 points in pilot study, reducing the probability of diabetes-related complications

Created by Versant Ventures and partnered with Fujifilm to develop iPSC-derived adaptive and innate immune effector cell therapies

Alkermes plc announced that for the 11th consecutive year, employees took a day out of the office to roll up their sleeves and volunteer with community organizations across the Greater Boston area as part of what was the company’s largest-ever annual day of service – Alkermes in Action.

Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, provided a mid-calendar year update on its corporate and clinical development programs.

OTC Markets Group Inc. announced Abacus Health Products Inc, a company engaged in the development and commercialization of over-the-counter topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD, has qualified to trade on the OTCQX® Best Market.